DAX22.933 +1,6%ESt505.388 +1,1%Top 10 Crypto11,67 +4,2%Dow40.814 -1,3%Nas17.303 -2,0%Bitcoin76.663 +2,6%Euro1,0893 +0,4%Öl70,30 +0,2%Gold2.994 +0,2%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 Tesla A1CX3T NVIDIA 918422 RENK RENK73 HENSOLDT HAG000 NEL ASA A0B733 thyssenkrupp 750000 Siemens Energy ENER6Y Daimler Truck DTR0CK Amazon 906866 BMW 519000 PUMA 696960 Allianz 840400 Volkswagen (VW) vz. 766403 Palantir A2QA4J
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Einigung auf Finanzpaket: DAX hebt ab -- Dow fester erwartet -- Daimler Truck: Gewinnrückgang -- BMW mit Margeneinbruch -- Energieaktien, HUGO BOSS, Goldpreis, PUMA im Fokus
Top News
Tesla-Aktie höher: Tesla warnt vor negativen Folgen durch Trump-Zölle - Heftige Vorwürfe gegen Arbeitspraxis in Grünheide Tesla-Aktie höher: Tesla warnt vor negativen Folgen durch Trump-Zölle - Heftige Vorwürfe gegen Arbeitspraxis in Grünheide
Aktien-Tipp: So bewertet UBS AG die Airbus SE (ex EADS)-Aktie Aktien-Tipp: So bewertet UBS AG die Airbus SE (ex EADS)-Aktie
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Regeneron Pharmaceuticals Aktie

NeuKaufenVerkaufen
Aktien-Sparplan anlegen
628,60 EUR +3,80 EUR +0,61 %
HAM
681,00 USD -8,03 USD -1,17 %
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.69,47 Mrd. EUR

KGV18,58Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN881535

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS75886F1075

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolREGN

Regeneron Pharmaceuticals Aktien News

DatumMeistgelesen
PR NewswireRegeneron Science Talent Search 2025 Awards More Than $1.8 Million to High School Seniors for Innovative Research on Classifying Celestial Objects, Treating a Rare Muscle Disease and Solving a Lon...
PR NewswireREGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
ZacksThe Zacks Analyst Blog Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals
Wer­bungRegeneron Pharmaceuticals-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireRegeneron Pharmaceuticals, Inc. (REGN) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
PR NewswireSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals
PR NewswireCLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Regeneron Pharmaceuticals (NASDAQ: REGN) Investors to Inquire About a Securities Fraud Class Action by March 10, 2025
PR NewswireRegeneron Pharmaceuticals, Inc. (REGN) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Regeneron Pharmaceuticals, Inc. - REGN
PR NewswireLevi & Korsinsky Notifies Regeneron Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - REGN
BenzingaPrice Over Earnings Overview: Regeneron Pharmaceuticals
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Regeneron Pharmaceuticals, Inc. - REGN
PR NewswireREGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit
BenzingaHere's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Regeneron Pharmaceuticals, Inc. - REGN
PR NewswireRegeneron Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - REGN
BenzingaHere's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 20 Years
PR NewswireMarch 10, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against REGN
MotleyFoolWhy Regeneron Pharmaceuticals Stock Topped the Market on Tuesday
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Regeneron Pharmaceuticals, Inc. - REGN
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - REGN
ZacksImplied Volatility Surging for Regeneron Pharmaceuticals (REGN) Stock Options
BenzingaBeyond The Numbers: 18 Analysts Discuss Regeneron Pharmaceuticals Stock
PR NewswireREGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit
PR NewswireContact The Gross Law Firm by March 10, 2025 Deadline to Join Class Action Against Regeneron Pharmaceuticals, Inc.(REGN)
PR NewswireAmerica's Top 40 High School Scientists to Compete for $1.8 Million in Awards at Prestigious Regeneron Science Talent Search
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - REGN
PR NewswireREGENERON EXPANDS PRESENCE IN CANADA BY OPENING ITS FIRST HEADQUARTERS TO BETTER SERVE NEEDS OF CANADIANS WITH SERIOUS DISEASES
PR NewswireREGENERON EXPANDS PRESENCE IN CANADA BY OPENING ITS FIRST HEADQUARTERS TO BETTER SERVE NEEDS OF CANADIANS WITH SERIOUS DISEASES
PR NewswireLevi & Korsinsky Reminds Regeneron Pharmaceuticals, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - REGN
PR NewswireREGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
PR NewswireREGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit
PR NewswireRegeneron Pharmaceuticals, Inc. Class Action: The Gross Law Firm Reminds Regeneron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - REGN
PR NewswireShareholders of Regeneron Pharmaceuticals, Inc. Should Contact Levi & Korsinsky Before March 10, 2025 to Discuss Your Rights - REGN
PR NewswireREGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
BenzingaForecasting The Future: 22 Analyst Projections For Regeneron Pharmaceuticals
PR NewswireRegeneron Pharmaceuticals (REGN) Faces Securities Class Action After Losing $9 Billion Value Following Q3 2024 Earnings Report- Hagens Berman
BusinesswireDEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Regeneron Pharmaceuticals
BenzingaWhat Analysts Are Saying About Regeneron Pharmaceuticals Stock
BenzingaWhat 25 Analyst Ratings Have To Say About Regeneron Pharmaceuticals
BenzingaRegeneron Pharmaceuticals Unusual Options Activity
Wer­bung

Regeneron Pharmaceuticals News

Regeneron Pharmaceuticals News: auf dieser Seite finden Sie alle Regeneron Pharmaceuticals News und Nachrichten zur Regeneron Pharmaceuticals Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Regeneron Pharmaceuticals News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Regeneron Pharmaceuticals News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.